Viewing Study NCT04849260


Ignite Creation Date: 2025-12-25 @ 2:10 AM
Ignite Modification Date: 2025-12-26 @ 12:37 AM
Study NCT ID: NCT04849260
Status: UNKNOWN
Last Update Posted: 2022-03-31
First Post: 2021-04-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase Ib/II Clinical Study of Pexa-Vec (Vaccinia GM CSF / Thymidine Kinase-Deactivated Virus) Combined With Recombinant Whole Human Anti-PD-L1 Monoclonal Antibody (ZKAB001) in Metastatic Melanoma
Sponsor: Lee's Pharmaceutical Limited
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module